Publicacions en col·laboració amb investigadors/es de Hospital Arnau de Vilanova (4)

2022

  1. Durvalumab After Sequential Chemoradiotherapy in Stage III, Unresectable NSCLC: The Phase 2 PACIFIC-6 Trial

    Journal of Thoracic Oncology, Vol. 17, Núm. 12, pp. 1415-1427

2012

  1. Phase III, randomized, double-blind, placebo-controlled trial of gemcitabine/cisplatin alone or with sorafenib for the first-line treatment of advanced, nonsquamous non-small-cell lung cancer

    Journal of Clinical Oncology, Vol. 30, Núm. 25, pp. 3084-3092

2010

  1. Treatment of cancer with oral drugs: A position statement by the Spanish Society of Medical Oncology (SEOM)

    Annals of Oncology

2005

  1. Phase II trial of the novel taxane BMS-184476 as second-line in non-small-cell lung cancer

    Annals of Oncology, Vol. 16, Núm. 4, pp. 597-601